A Safety and Efficacy Study of Oral Prolonged-Release Fampridine (BIIB041) in Japanese Participants With Multiple Sclerosis

Clinical trial NCT01917019 · COMPLETED

Trial details

NCT number: NCT01917019
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Sclerosis, Remittent Progressive Multiple Sclerosis, Primary Progressive Relapsing-Remitting Multiple Sclerosis Secondary Progressive Multiple Sclerosis Multiple Sclerosis

Start date: 2013-08-01
Primary completion: 2015-10-01
Enrollment: 101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.